Brickell Biotech Stock Retained Earnings
| BBIDelisted Stock | USD 1.79 0.34 23.45% |
Brickell Biotech fundamentals help investors to digest information that contributes to Brickell Biotech's financial success or failures. It also enables traders to predict the movement of Brickell Stock. The fundamental analysis module provides a way to measure Brickell Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Brickell Biotech stock.
Brickell |
Brickell Biotech Company Retained Earnings Analysis
Brickell Biotech's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Brickell Biotech Retained Earnings | (145.37 M) |
Most of Brickell Biotech's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Brickell Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
CompetitionBased on the latest financial disclosure, Brickell Biotech has a Retained Earnings of (145.37 Million). This is 115.61% lower than that of the Biotechnology sector and 250.03% lower than that of the Health Care industry. The retained earnings for all United States stocks is 101.56% higher than that of the company.
Brickell Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Brickell Biotech's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Brickell Biotech could also be used in its relative valuation, which is a method of valuing Brickell Biotech by comparing valuation metrics of similar companies.Brickell Biotech is currently under evaluation in retained earnings category among its peers.
Brickell Fundamentals
| Return On Equity | -1.57 | |||
| Return On Asset | -0.8 | |||
| Operating Margin | (6.58) % | |||
| Current Valuation | (8.35 M) | |||
| Shares Outstanding | 2.87 M | |||
| Shares Owned By Insiders | 1.20 % | |||
| Shares Owned By Institutions | 13.07 % | |||
| Number Of Shares Shorted | 189.59 K | |||
| Price To Earning | (35.16) X | |||
| Price To Book | 0.41 X | |||
| Price To Sales | 1.45 X | |||
| Revenue | 404 K | |||
| Gross Profit | (27.83 M) | |||
| EBITDA | (39.38 M) | |||
| Net Income | (39.47 M) | |||
| Cash And Equivalents | 17.29 M | |||
| Cash Per Share | 6.52 X | |||
| Total Debt | 69 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 4.36 X | |||
| Book Value Per Share | 5.81 X | |||
| Cash Flow From Operations | (36.15 M) | |||
| Short Ratio | 0.62 X | |||
| Earnings Per Share | (0.42) X | |||
| Target Price | 17.83 | |||
| Number Of Employees | 16 | |||
| Beta | 0.0796 | |||
| Market Capitalization | 6.75 M | |||
| Total Asset | 29.72 M | |||
| Retained Earnings | (145.37 M) | |||
| Working Capital | 24.79 M | |||
| Current Asset | 52.66 M | |||
| Current Liabilities | 5.61 M | |||
| Net Asset | 29.72 M |
About Brickell Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Brickell Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brickell Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brickell Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Brickell Stock
If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |